Division News

  • Sickle-Cell Patients See Hope in CRISPR

    By Emily Mullin

    The disease may be among the first to be treated with the novel gene-editing tool.

  • Stanford Center for Definitive and Curative Medicine to tackle genetic diseases

    By Becky Bach

    Good news for people suffering from genetic diseases and for those who could be helped with stem cell therapies. This week, Stanford announced the creation of the Center for Definitive and Curative Medicine, a new center that aims to bring life-changing advances to millions of patients.

  • Use caution when editing genes, new report advises

    By Erin Digitale

    New gene-editing techniques are making it easier, cheaper and more efficient to rewrite the DNA of living organisms. But these methods — such as CRISPR — raise challenging questions about the ethics of editing the human genome.

  • Finding the Cures Within Us

    By Greta Lorge

    Stem cell research holds the promise of a sea change in medicine. At Stanford, momentum is building.

  • Making Sickle Cells Well

    BREAKTHROUGHS, BRIEFLY

    School of Medicine Research led by associate professor Matthew Porteus, MD ’94, PhD ’94, may advance to human gene-therapy trials to treat sickle cell disease by next year. That, anyway, is the timetable Porteus is hoping for following his team’s promising use of the gene-editing technique known as CRISPR to correct the gene mutation that produces misshapen—sickle-shaped—red blood cells.

  • Gene Therapy 2.0

    By Emily Mullin

    Scientists have solved fundamental problems that were holding back cures for rare hereditary disorders. Next we’ll see if the same approach can take on cancer, heart disease, and other common illnesses.

  • Gene-Editing Gets A Go-Ahead

    Guest host Anthony Brooks

    Growing support for human gene-editing. We’ll look at new breakthroughs and the ethical debate

    Those in the know call CRISPR “one of the greatest life science inventions ever.” It has sparked a headline-grabbing patent fight worth billions of dollars. But more importantly, it has revolutionized the ability to make precise changes to human DNA, opening the door to revolutionary ways to treat disease – but also to ethical questions about engineered designer babies. This hour On Point, the brave new world of human DNA editing and CRISPR.

  • Stanford scientists describe stem-cell and gene-therapy advances in scientific symposium

    By Erin Digitale

    Using stem cells and gene therapy to treat or cure disease may still sound like science fiction, but a scientific meeting here last week emphasized all the fronts on which it is moving closer and closer to fact.

  • Chan Zuckerberg Biohub Names Investigators, Builds Collaborative Culture

    By Allison Proffitt

    The Chan Zuckerberg Biohub has named its first cohort of 47 investigators from the University of California, Berkeley, Stanford University and the University of California, San Francisco.

  • Faculty members receive grants from state stem cell agency


    The grants to Stanford researchers target stem cell-based therapies for autoimmune disorders, liver disease and cystic fibrosis.

    Three researchers from the School of Medicine have been awarded grants by the governing board of the California Institute for Regenerative Medicine to promote the discovery of potential stem cell-based therapies.